Eikon Therapeutics
Discovers drugs using advanced live-cell imaging and protein tracking.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2019
- Employees
- 398
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: EIKN
Open positions
4 jobs
1 views 2 days ago
Director, Optical Engineering
NewBe an early applicant North America
United States
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening…
Assembly Proof of Concept Prototyping Regulatory Compliance